Adagene, Inc. (NASDAQ:ADAG) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Cuong Do Other companies: BioVie Inc. (President & Chief Executive Officer · Since at least Jul 1, 2018); Spark I Acquisition Corp. (Director · Oct 5, 2023 – Oct 5, 2023 · Past); Merck & Company, Inc. (EVP & Chief Strategy Officer · Oct 3, 2011 – May 6, 2013 · Past); TE Connectivity plc (SVP, Corp. Strategy & Bus. Dev · Jun 16, 2010 – Sep 15, 2011 · Past) | Independent Director · Since at least Mar 18, 2026 |
| Alexander Goergen | Vice President, Head of Business Development · Since at least Nov 5, 2026 |
| Andy Cheung | Independent Director · Since at least Nov 4, 2026 |
| Chunfang Gu | Executive Director of Finance · Since at least Mar 18, 2026 |
| Guizhong Liu | Senior Vice President of Early Drug Discovery · Since at least Nov 5, 2026 |
| Jiping Zha | Executive Vice President, Clinical Development · Since at least Nov 5, 2026 |
| Kristine She | Senior Vice President, Head of Clinical Operations · Since at least Nov 5, 2026 |
| Ling Zhou | Executive Director, Head of Human Resources · Since at least Mar 18, 2026 |
| Li Zhu | Director · Since at least Mar 18, 2026 |
| Man Kin Tam | Chief Financial Officer · Since at least Nov 5, 2026 |
| Mickael Chane-Du | Chief Strategy Officer · Since at least Mar 18, 2026 |
| Peter Luo | Chairman of the Board of Directors · Since at least Mar 18, 2026 |
| Qinghai Zhao | Chief Manufacturing Officer · Since at least Nov 5, 2026 |
| Songmao Zheng | Senior Vice President of Clinical Pharmacology and Quantitative Sciences · Since at least Nov 5, 2026 |
| Ulf Grawunder | Independent Director · Since at least Mar 17, 2026 |
| Wenlin Zeng | Vice President of Early Stage CMC · Since at least Nov 5, 2026 |
| Yan Li | Senior Vice President, Bioinformatics and Information Technology · Since at least Nov 5, 2026 |
| Zhu Li | Independent Director · Since at least Nov 5, 2026 |